253 related articles for article (PubMed ID: 12109867)
1. T-peak to T-end interval may be a better predictor of high-risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin I mutation than QT dispersion.
Shimizu M; Ino H; Okeie K; Yamaguchi M; Nagata M; Hayashi K; Itoh H; Iwaki T; Oe K; Konno T; Mabuchi H
Clin Cardiol; 2002 Jul; 25(7):335-9. PubMed ID: 12109867
[TBL] [Abstract][Full Text] [Related]
2. Chronologic electrocardiographic changes in patients with hypertrophic cardiomyopathy associated with cardiac troponin 1 mutation.
Shimizu M; Ino H; Yamaguchi M; Terai H; Hayashi K; Kiyama M; Sakata K; Hayashi T; Inoue M; Kaneda T; Mabuchi H
Am Heart J; 2002 Feb; 143(2):289-93. PubMed ID: 11835033
[TBL] [Abstract][Full Text] [Related]
3. QRS Fragmentation and QTc Duration Relate to Malignant Ventricular Tachyarrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy.
Debonnaire P; Katsanos S; Joyce E; VAN DEN Brink OV; Atsma DE; Schalij MJ; Bax JJ; Delgado V; Marsan NA
J Cardiovasc Electrophysiol; 2015 May; 26(5):547-55. PubMed ID: 25648421
[TBL] [Abstract][Full Text] [Related]
4. QT spatial dispersion and sudden cardiac death in hypertrophic cardiomyopathy: Time for reappraisal.
Magrì D; Santolamazza C; Limite L; Mastromarino V; Casenghi M; Orlando P; Pagannone E; Musumeci MB; Maruotti A; Ricotta A; Oliviero G; Piccirillo G; Volpe M; Autore C
J Cardiol; 2017 Oct; 70(4):310-315. PubMed ID: 28341542
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene.
Kokado H; Shimizu M; Yoshio H; Ino H; Okeie K; Emoto Y; Matsuyama T; Yamaguchi M; Yasuda T; Fujino N; Ito H; Mabuchi H
Circulation; 2000 Aug; 102(6):663-9. PubMed ID: 10931807
[TBL] [Abstract][Full Text] [Related]
6. Is QT dispersion associated with sudden cardiac death in patients with hypertrophic cardiomyopathy?
Yi G; Poloniecki J; Dickie S; Elliott PM; Malik M; McKenna WJ
Ann Noninvasive Electrocardiol; 2001 Jul; 6(3):209-15. PubMed ID: 11466139
[TBL] [Abstract][Full Text] [Related]
7. Impact of QT variables on clinical outcome of genotyped hypertrophic cardiomyopathy.
Uchiyama K; Hayashi K; Fujino N; Konno T; Sakamoto Y; Sakata K; Kawashiri MA; Ino H; Yamagishi M
Ann Noninvasive Electrocardiol; 2009 Jan; 14(1):65-71. PubMed ID: 19149795
[TBL] [Abstract][Full Text] [Related]
8. NOS1AP Polymorphisms Modify QTc Interval Duration But Not Cardiac Arrest Risk in Hypertrophic Cardiomyopathy.
Earle N; Ingles J; Bagnall RD; Gray B; Crawford J; Smith W; Shelling AN; Love DR; Semsarian C; Skinner JR
J Cardiovasc Electrophysiol; 2015 Dec; 26(12):1346-51. PubMed ID: 26332198
[TBL] [Abstract][Full Text] [Related]
9. QT prolongation and sudden cardiac death risk in hypertrophic cardiomyopathy.
Patel SI; Ackerman MJ; Shamoun FE; Geske JB; Ommen SR; Love WT; Cha SS; Bos JM; Lester SJ
Acta Cardiol; 2019 Feb; 74(1):53-58. PubMed ID: 29513133
[TBL] [Abstract][Full Text] [Related]
10. Correlations between cardiac troponin I and nonsustained ventricular tachycardia in hypertrophic obstructive cardiomyopathy.
Liu L; Liu S; Shen L; Tu B; Hu Z; Hu F; Zheng L; Ding L; Fan X; Yao Y
Clin Cardiol; 2020 Oct; 43(10):1150-1159. PubMed ID: 32810305
[TBL] [Abstract][Full Text] [Related]
11. The relationship between myocardial fibrosis detected by cardiac magnetic resonance and Tp-e interval, 5-year sudden cardiac death risk score in hypertrophic cardiomyopathy patients.
Riza Demir A; Celik Ö; Sevinç S; Uygur B; Kahraman S; Yilmaz E; Cemek M; Onal Y; Erturk M
Ann Noninvasive Electrocardiol; 2019 Sep; 24(5):e12672. PubMed ID: 31152489
[TBL] [Abstract][Full Text] [Related]
12. Ambulatory assessment of the QT interval in patients with hypertrophic cardiomyopathy: risk stratification and effect of low dose amiodarone.
Fei L; Slade AK; Grace AA; Malik M; Camm AJ; McKenna WJ
Pacing Clin Electrophysiol; 1994 Nov; 17(11 Pt 2):2222-7. PubMed ID: 7845847
[TBL] [Abstract][Full Text] [Related]
13. Ventricular Repolarization Dispersion is a Potential Risk for the Development of Life-Threatening Arrhythmia in Children with Hypertrophic Cardiomyopathy.
Tashiro N; Muneuchi J; Ezaki H; Kobayashi M; Yamada H; Sugitani Y; Watanabe M
Pediatr Cardiol; 2022 Oct; 43(7):1455-1461. PubMed ID: 35284943
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of electrocardiographic time intervals and QT rate dependence in hypertrophic cardiomyopathy.
Robyns T; Nuyens D; Lu HR; Gallacher DJ; Vandenberk B; Garweg C; Ector J; Pagourelias E; Van Cleemput J; Janssens S; Willems R
J Electrocardiol; 2018; 51(6):1077-1083. PubMed ID: 30497734
[TBL] [Abstract][Full Text] [Related]
15. Short-term beat-to-beat variability of the QT interval is increased and correlates with parameters of left ventricular hypertrophy in patients with hypertrophic cardiomyopathy.
Orosz A; Baczkó I; Nagy V; Gavallér H; Csanády M; Forster T; Papp JG; Varró A; Lengyel C; Sepp R
Can J Physiol Pharmacol; 2015 Sep; 93(9):765-72. PubMed ID: 26313025
[TBL] [Abstract][Full Text] [Related]
16. Can the assessment of dynamic QT dispersion on exercise electrocardiogram predict sudden cardiac death in hypertrophic cardiomyopathy?
Yi G; Poloniecki J; Dickie S; Elliott PM; Malik M; McKenna WJ
Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):1953-6. PubMed ID: 11139965
[TBL] [Abstract][Full Text] [Related]
17. Relationship between the QT indices and the microvolt-level T wave alternans in cardiomyopathy.
Kuroda N; Ohnishi Y; Adachi K; Yokoyama M
Jpn Circ J; 2001 Nov; 65(11):974-8. PubMed ID: 11716250
[TBL] [Abstract][Full Text] [Related]
18. Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy.
Mori AA; Castro LR; Bortolin RH; Bastos GM; Oliveira VF; Ferreira GM; Hirata TDC; Fajardo CM; Sampaio MF; Moreira DAR; Pachón-Mateos JC; Correia EB; Sousa AGMR; Brión M; Carracedo A; Hirata RDC; Hirata MH
Forensic Sci Int Genet; 2021 May; 52():102478. PubMed ID: 33588347
[TBL] [Abstract][Full Text] [Related]
19. Exercise-induced changes in the QT interval duration and dispersion in patients with sudden cardiac death after myocardial infarction.
Yi G; Crook R; Guo XH; Staunton A; Camm AJ; Malik M
Int J Cardiol; 1998 Feb; 63(3):271-9. PubMed ID: 9578355
[TBL] [Abstract][Full Text] [Related]
20. QT-interval abnormalities in hypertrophic cardiomyopathy.
Dritsas A; Sbarouni E; Gilligan D; Nihoyannopoulos P; Oakley CM
Clin Cardiol; 1992 Oct; 15(10):739-42. PubMed ID: 1395184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
